Methods
Endogenous PTEN in vitro lipid phosphatase assay. PTEN phosphatase activity was measured in vitro. Briefly, immunoprecipitations were carried out with an anti-PTEN antibody (Santa Cruz Biotechnology) overnight and a secondary agaroseconjugate antibody for 3 hours at 4ºC. Immunoprecipitated protein was washed, resuspended in enzyme reaction buffer (50mM Tris, pH 8; 50mM NaCl; 10mM DTT and 10mM MgCl 2 ), and incubated with 10µM PIP3 (Echelon) for 30 min at 37ºC, after which phosphatase reaction was stopped with 100µL malachite green reagent (Echelon).
Free phosphatase levels were measured in an ELISA plate reader at 630nm. Absorbance was converted into pmol phosphate using a phosphate standard curve.
Endogenous CK2 in vitro kinase assay. CK2 activity was measured using the Casein Kinase 2 Assay Kit (Millipore), according to the manufacturer's instructions.
Briefly, protein lysates were incubated for 10 minutes at 30°C in a reaction mixture containing a CK2-specific peptide, [γ- 32 P]ATP (PerkinElmer) and a PKA inhibitor cocktail. The radioactivity incorporated into the substrate was determined by scintillation counting. The kinase activity was calculated by subtracting the background for each sample (without substrate).
Immunoblotting. Cells were lysed in 50mM Tris-HCl pH 8.0, 150mM NaCl, 5mM
EDTA, 1% (v/v) NP-40, 1mM Na3VO4, 10mM NaF, 10mM NaPyroph, 1mM 4-(2-aminoethyl) benzenesulfonyl (AEBSF), 10μg/ml leupeptin, 10μg/ml aprotinin, 1μg/ml Pepstatin, resolved by 10% SDS-PAGE, transferred onto nitrocellulose membranes, and 
